Published in J Virol on December 01, 2000
Real time quantitative PCR. Genome Res (1996) 35.79
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
Developments in quantitative PCR. Clin Chem Lab Med (1998) 8.72
Gene therapy -- promises, problems and prospects. Nature (1997) 6.02
Non-contiguous segments of the polyoma genome required in cis for DNA replication. J Mol Biol (1982) 3.03
Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol (1975) 2.17
Cooperation of structural proteins during late events in the life cycle of polyomavirus. J Virol (1993) 1.58
Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur J Immunol (1993) 1.14
Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum Gene Ther (1995) 1.04
Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids. Gene Ther (1998) 0.94
Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids. Gene Ther (2000) 0.91
Interactions of heterologous DNA with polyomavirus major structural protein, VP1. FEBS Lett (1999) 0.91
Persistence of polyomavirus in mice infected as adults differs from that observed in mice infected as newborns. J Virol (1993) 0.86
Adult X-linked immunodeficiency (XID) mice, IGM-/- single knockout and IGM-/- CD8-/- double knockout mice do not clear polyomavirus infection. In Vivo (1998) 0.82
Polyomavirus persists in CD4/8 double-knockout, but not in CD4 or CD8 single-knockout mice. Virology (1995) 0.80
Studies on polyomavirus persistence and polyomavirus-induced tumor development in relation to the immune system. Adv Cancer Res (2000) 0.79
Coding potential and regulatory signals of the polyoma virus genome. Nature (1980) 11.24
Polyoma DNA: a physical map. Proc Natl Acad Sci U S A (1974) 7.36
Organization of the genomes of polyoma virus and SV40. Adv Cancer Res (1977) 3.53
Sequence from early region of polyoma virus DNA containing viral replication origin and encoding small, middle and (part of) large T antigens. Cell (1979) 3.29
Isolation of human lymphotropic herpesviruses from Uganda. Lancet (1987) 3.26
EBV gene expression in an NPC-related tumour. EMBO J (1989) 2.94
Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Res (1981) 2.83
New classes of viable deletion mutants in the early region of polyoma virus. J Virol (1979) 2.75
Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol (1981) 2.43
The synthesis of oligoribonucleotides. IV. Preparation of dinucleoside phosphates from 2',5'-protected ribonucleoside derivatives. Tetrahedron (1968) 2.31
5 s RNA conformation. Studies of its partial T 1 ribonuclease digestion by gel electrophoresis and two-dimensional thin-layer chromatography. J Mol Biol (1972) 2.21
Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer (2000) 2.17
Polyoma virus--a study of wild-type, mutant and defective DNAs. Cold Spring Harb Symp Quant Biol (1975) 2.17
Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol (1989) 2.10
Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol (1996) 2.03
The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus. EMBO J (1984) 2.00
Myristic acid is coupled to a structural protein of polyoma virus and SV40. Nature (1987) 1.98
Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res (1995) 1.96
Middle T antigen as primary inducer of full expression of the phenotype of transformation by polyoma virus. J Virol (1980) 1.96
Amplification of a specific region of the polyoma virus genome. Nature (1975) 1.92
Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J Virol (1985) 1.91
Immortalization of monkey epithelial cells by specific fragments of Epstein-Barr virus DNA. Nature (1984) 1.90
Monoclonal antibodies against polyoma virus tumor antigens. Proc Natl Acad Sci U S A (1982) 1.73
Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J Virol (1992) 1.66
Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. Proc Natl Acad Sci U S A (1992) 1.66
Cooperation of structural proteins during late events in the life cycle of polyomavirus. J Virol (1993) 1.58
Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells. Nucleic Acids Res (1991) 1.57
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol (2000) 1.57
Oligoribonucleotide synthesis from nucleoside 2'-O-benzyl ethers. Tetrahedron Lett (1966) 1.54
Coding capacity of a 35 percent fragment of the polyoma virus genome is sufficient to initiate and maintain cellular transformation. Proc Natl Acad Sci U S A (1980) 1.53
Clustered repeat sequences in the genome of Epstein Barr virus. Nucleic Acids Res (1983) 1.53
Studies and sequences of Escherichia coli 4.5 S RNA. J Biol Chem (1975) 1.52
DNA sequences of polyoma virus early deletion mutants. J Virol (1981) 1.51
Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest (1994) 1.48
Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology (1992) 1.47
DNA binding activity of polyoma virus large tumor antigen. Proc Natl Acad Sci U S A (1984) 1.47
Fine structure of polyoma virus DNA. J Mol Biol (1977) 1.45
Typing of human papillomavirus by pyrosequencing. Lab Invest (2001) 1.44
Sequences from the genome of a non-transforming mutant of polyoma virus. Nature (1978) 1.41
The synthesis of oligoribonucleotides. II. Methoxymethylidene derivatives of ribonucleosides and 5'-ribonucleotides. Tetrahedron (1967) 1.39
Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product? Cold Spring Harb Symp Quant Biol (1980) 1.39
Polyoma virus DNA: complete nucleotide sequence of the gene which codes for polyoma virus capsid protein VP1 and overlaps the VP2/VP3 genes. J Virol (1980) 1.36
EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J (1994) 1.29
Host-dependent evolution of three papova viruses. Nature (1980) 1.28
Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines. Mol Biol Med (1984) 1.27
Scanning surface confocal microscopy for simultaneous topographical and fluorescence imaging: application to single virus-like particle entry into a cell. Proc Natl Acad Sci U S A (2002) 1.24
The synthesis of oligoribonucleotides. 3. Monoacylation of ribonucleosides and derivatives via orthoester exchange. Tetrahedron (1967) 1.24
Asymptomatic human carriers of Leishmania infantum: possible reservoirs for Mediterranean visceral leishmaniasis in southern Iran. Ann Trop Med Parasitol (2008) 1.24
The acetic acid test in evaluation of subclinical genital papillomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med (1992) 1.21
Characterization of the DNA polymerase gene of human herpesvirus 6. J Virol (1991) 1.21
Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J Virol (1993) 1.19
Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen. Nucleic Acids Res (1988) 1.18
Polyoma virus. The early region and its T-antigens. Nucleic Acids Res (1979) 1.18
Chrysomya bezziana as a Causative Agent of Human Myiasis in Fars Province, Southern Iran. Iran J Arthropod Borne Dis (2009) 1.18
Myristylated polyomavirus VP2: role in the life cycle of the virus. J Virol (1990) 1.17
A Preliminary Genetic Investigation of VOLVOX CARTERI. Genetics (1979) 1.17
Polyomavirus: an overview of its unique properties. Adv Cancer Res (1983) 1.16
Psychological issues in inflammatory bowel disease: an overview. Gastroenterol Res Pract (2012) 1.16
Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene (1995) 1.14
Immortalization and transformation of human fibroblasts by regulated expression of polyoma virus T antigens. Oncogene (1990) 1.14
Rodent infection with Leishmania in a new focus of human cutaneous leishmaniasis, in northern Iran. Ann Trop Med Parasitol (2008) 1.13
Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer (2003) 1.11
The PCR-based detection and identification of the parasites causing human cutaneous leishmaniasis in the Iranian city of Ahvaz. Ann Trop Med Parasitol (2011) 1.10
Requirement for the C-terminal region of middle T-antigen in cellular transformation by polyoma virus. Nucleic Acids Res (1981) 1.10
Polyoma virus DNA: Sequence from the late region that specifies the leader sequence for late mRNA and codes for VP2, VP3, and the N-terminus of VP1. J Virol (1980) 1.10
Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids. Gene Ther (2000) 1.08
The PCR-based detection of Leishmania major infections in Meriones libycus (Rodentia: Muridae) from southern Iran. Ann Trop Med Parasitol (2003) 1.06
Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum Gene Ther (1995) 1.04
Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy. Med Pediatr Oncol (2003) 1.03
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts. Bone Marrow Transplant (2008) 1.03
Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location. Proc Natl Acad Sci U S A (1987) 1.01
Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma. J Med Virol (1998) 1.01
Characterization of genotype-specific epitopes of the HN protein of mumps virus. J Gen Virol (1997) 1.01
Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome. Clin Exp Immunol (1989) 1.01
Precursors of stable RNA accumulated in a mutant of E. coli. FEBS Lett (1973) 0.99
Comparison of three methods for diagnosis of cutaneous leishmaniasis. Iran J Parasitol (2010) 0.99
A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol (2000) 0.98
CpG methylation of viral DNA in EBV-associated tumours. Int J Cancer (1990) 0.98
Correlation of glycosphingolipids and sialic acid in YAC-1 lymphoma variants with their sensitivity to natural killer-cell-mediated lysis. Int J Cancer (1981) 0.97
Subcellular localisation of the middle and large T-antigens of polyoma virus. EMBO J (1986) 0.97
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol (2004) 0.96
Genetic control of somatic cell differentiation in Volvox analysis of somatic regenerator mutants. Dev Biol (1979) 0.96
Variation in restriction map of MHV-6 genome. Lancet (1989) 0.96
The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother (1992) 0.95
Antibodies against a nonapeptide of polyomavirus middle T antigen: cross-reaction with a cellular protein(s). J Virol (1983) 0.95
Human papillomavirus deoxyribonucleic acid in cervix only detected in girls after coitus. Int J STD AIDS (1997) 0.95
Pulse oximetry: what's normal in the newborn nursery? Pediatr Pulmonol (2000) 0.95
Are plant factors a missing link in the evolution of endemic Burkitt's lymphoma? Br J Cancer (1993) 0.94
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant (1995) 0.94
Efficient oligodeoxyribonucleotide-directed deletion mutagenesis using pEMBL vectors: removal of early region introns from polyoma virus mutants. Gene (1986) 0.94
Enhancement by polylysine of transient, but not stable, expression of genes carried into cells by polyoma VP1 pseudocapsids. Gene Ther (1998) 0.94
Orientation of ribonucleoside derivatives by proton magnetic resonance spectroscopy. Tetrahedron (1966) 0.94
Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival. Anticancer Res (2001) 0.92
Polyoma virus defective DNAs. I. Physical maps of a related set of defective molecules (D76, D91, D92). J Mol Biol (1977) 0.92
Polyoma virus defective DNAs. II. Physical map of a molecule with rearranged and reiterated sequences (D74). J Mol Biol (1977) 0.92
Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: correlation with patient response to therapy. Int J Cancer (1999) 0.92